| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1429109A Compositions comprising blockers of L-DOPA renal cell transfer for treatment of Parkinson's disease |
| 07/09/2003 | CN1429102A Hydrogel composition for transdermal drug delivery |
| 07/09/2003 | CN1428336A Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 07/09/2003 | CN1428334A Alkaloid compound, pain-stopping medicine and its preparation method |
| 07/09/2003 | CN1428157A Medicine for curing migraine |
| 07/09/2003 | CN1428146A Injection containing tramadol and its application |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113963C Preparation and application of rhBTR gene and gene probe |
| 07/09/2003 | CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives |
| 07/09/2003 | CN1113874C Benzocycloalkylazolethione derivatives |
| 07/09/2003 | CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline |
| 07/09/2003 | CN1113867C Amino anthracyclinone derivatives and their use in treatment of amyloidosis |
| 07/09/2003 | CN1113666C Drug-dropping tea and its preparing method |
| 07/09/2003 | CN1113658C External-use medicine for treating facial palsy and its preparation method |
| 07/08/2003 | US6590085 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/08/2003 | US6589986 Methods of treating anxiety disorders |
| 07/08/2003 | US6589985 Halogenated 2-phenyl-1,2-ethanediol monocarbamate or dicarbamate compounds |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
| 07/08/2003 | US6589965 Method of treating and preventing migraine headaches |
| 07/08/2003 | US6589960 Preparation of a ketone from a narcotic alkaloid having an allyl alcohol moiety is disclosed. The method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the absence of |
| 07/08/2003 | US6589958 Isoxazolo [4,5-d] pyrimidines as CRF antagonists |
| 07/08/2003 | US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist. |
| 07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
| 07/08/2003 | US6589953 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 07/08/2003 | US6589952 Imidazo[1,2-a]pyrazines for the treatment of neurological disorders |
| 07/08/2003 | US6589949 3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases |
| 07/08/2003 | US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 07/08/2003 | US6589944 A method of cleaving glycation endproducts or cross-linked proteins in an organism in need thereof, wherein said method comprises administering an effective amount of a compound or pharmaceutically acceptable salt thereof to said organism for |
| 07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 07/08/2003 | US6589747 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 07/08/2003 | CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 07/08/2003 | CA2271841C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 07/08/2003 | CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them |
| 07/08/2003 | CA2153549C New benzothiadiazine derivative, process for preparing the same and pharmaceutical compositions containing said derivative |
| 07/08/2003 | CA2151096C New 1,4-oxazine tetracyclic derivatives; process for preparing them and pharmaceutical copossitions containing them |
| 07/07/2003 | CA2415591A1 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/03/2003 | WO2003054226A2 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 07/03/2003 | WO2003054190A1 Novel proteins and dnas thereof |
| 07/03/2003 | WO2003054077A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 07/03/2003 | WO2003054014A2 Apolipoprotein biopolymer markers predictive of alzheimers disease |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054009A2 Apoptotically active peptides |
| 07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
| 07/03/2003 | WO2003053979A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | WO2003053978A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 07/03/2003 | WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity |
| 07/03/2003 | WO2003053973A1 Pyrazolyl-substituted triazoloquinoxalines |
| 07/03/2003 | WO2003053970A1 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053968A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 07/03/2003 | WO2003053967A1 Aroyl pyridinones |
| 07/03/2003 | WO2003053961A1 Benzothiazoles |
| 07/03/2003 | WO2003053957A1 Benzhydryl derivatives |
| 07/03/2003 | WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | WO2003053954A1 Benzothiophenes as adenosine receptor modulators |
| 07/03/2003 | WO2003053948A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | WO2003053947A1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 07/03/2003 | WO2003053946A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 07/03/2003 | WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists |
| 07/03/2003 | WO2003053942A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 07/03/2003 | WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053936A1 Dopamine d1 receptor agonist pro-drug compounds & derivatives |
| 07/03/2003 | WO2003053928A1 Serotonine reuptake inhibitor |
| 07/03/2003 | WO2003053927A1 Piperazine derivative |
| 07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators |
| 07/03/2003 | WO2003053922A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053476A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles |
| 07/03/2003 | WO2003053467A1 Drug for regenerating tissue and vessel and method therefor |
| 07/03/2003 | WO2003053445A1 Use of desoxypeganine for treating clinical depression |
| 07/03/2003 | WO2003053444A1 New use |
| 07/03/2003 | WO2003053442A1 Tempamine compositions and methods of use |
| 07/03/2003 | WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 07/03/2003 | WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 07/03/2003 | WO2003053433A1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 07/03/2003 | WO2003053431A2 Pharmaceutical compositions based on azetidine derivatives |
| 07/03/2003 | WO2003053429A2 2-indanylamino derivatives for the therapy of chronic pain |
| 07/03/2003 | WO2003053426A1 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 07/03/2003 | WO2003053425A1 Treatment of neurodegenerative and cardiovascular disorders |
| 07/03/2003 | WO2003053417A2 Method for making a tablet comprising a morphine type analgesic and resulting tablet |
| 07/03/2003 | WO2003053407A1 Liposomal delivery of vitamin e based compounds |
| 07/03/2003 | WO2003053400A1 Formulation & dosage form for the controlled delivery of therapeutic agents |
| 07/03/2003 | WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 07/03/2003 | WO2003053359A2 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| 07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells |
| 07/03/2003 | WO2003053336A2 Methods for the treatment of peripheral neural and vascular ailments |
| 07/03/2003 | WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/03/2003 | WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 |
| 07/03/2003 | WO2003053328A1 Composition comprising marked befloxatone |